Adient
ADNTNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $16.13 Prior regular-session close from the quote source.
- $15.80–$16.51 Regular-session low and high so far today.
- 911.5K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $15.80–$27.32 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own ADNT if Adient is a cyclical automotive-seating turnaround whose upside depends on converting entrenched OEM program positions into durable cash profit despite weak supplier pricing power.
ADNT price history
Loading recent earnings…
Investment thesis
What must happen next
Adient’s embedded role in global OEM seating programs remains a real demand anchor, so losses of vehicle-platform awards should be cyclical and mix-driven rather than a structural share loss.HoldingMateriality: High
Profile describes Adient as a global leader in the automotive seating supply industry with leading market positions in the Americas, Europe and Asia. If program stickiness holds, revenue can stabilize through auto-cycle noise; if it breaks, the turnaround loses its base load of demand.
Watch: Lear, Forvia, Toyota Boshoku or other seating suppliers win major upcoming OEM platform awards that Adient previously held.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Profile describes Adient as a global leader in the automotive seating supply industry with leading market positions in the Americas.
Open source ↗Adient can defend gross economics only if launch execution, purchasing discipline and customer cost recoveries offset OEM price pressure and input-cost inflation.HoldingMateriality: High
GAAP annual gross_profit rose to $961 million in FY2025 from $928 million in FY2024 despite lower GAAP annual revenue. Gross-profit resilience is the first sign that scale is creating supplier economics rather than merely passing OEM volume through at low return.
Watch: OEMs impose price-downs or delay recovery of labor, freight, commodity or launch costs.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual gross_profit rose to $961 million in FY2025 from $928 million in FY2024 despite lower GAAP annual revenue.
Open source ↗The turnaround remains financeable if Adient’s working-capital discipline, customer reimbursements and restructuring actions keep operating cash generation positive despite thin margins.HoldingMateriality: Medium
GAAP annual operating_cash_flow was positive at $449 million in FY2025 despite a GAAP annual net loss. Positive operating cash flow gives Adient time to fix program economics; a cash drain would shift value to creditors and force defensive actions.
Watch: OEM production cuts reduce plant utilization and delay receivable collection or tooling reimbursements.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating_cash_flow was positive at $449 million in FY2025 despite a GAAP annual net loss.
Open source ↗Adient’s cash balance gives it a runway to absorb seating-cycle volatility, but that runway only matters if it is not consumed by refinancing, restructuring or customer-volume shocks.HoldingMateriality: Medium
Cash was $958 million at FY2025 year-end, slightly above $945 million at FY2024 year-end. Liquidity determines whether shareholders own a recoverable cyclical trough or a balance-sheet problem.
Watch: Debt maturities or refinancing occur at materially higher interest cost, reducing flexibility before operations recover.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash was $958 million at FY2025 year-end, slightly above $945 million at FY2024 year-end.
Open source ↗Adient’s scale creates shareholder value only if cost recovery and operating discipline flow through below gross profit into sustained GAAP net profitability.WeakeningMateriality: Medium
Adient produced positive GAAP annual net_income of $205 million in FY2023 and $18 million in FY2024, showing profitability is possible when costs and production align. Without net profitability, the business may remain essential to OEMs but still fail to compound per-share value for owners.
Watch: OEM pricing pressure permanently captures the benefit of Adient’s purchasing, footprint and launch improvements.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Adient produced positive GAAP annual net_income of $205 million in FY2023 and $18 million in FY2024, showing profitability is possible.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Adient’s embedded role in global OEM seating programs remains a real demand anchor, so losses of vehicle-platform awards should be cyclical and mix-driven rather than a structural share loss. If program stickiness holds, revenue can stabilize through auto-cycle noise; if it breaks, the turnaround loses its base load of demand.
Adient can defend gross economics only if launch execution, purchasing discipline and customer cost recoveries offset OEM price pressure and input-cost inflation. Gross-profit resilience is the first sign that scale is creating supplier economics rather than merely passing OEM volume through at low return.
The turnaround remains financeable if Adient’s working-capital discipline, customer reimbursements and restructuring actions keep operating cash generation positive despite thin margins. Positive operating cash flow gives Adient time to fix program economics; a cash drain would shift value to creditors and force defensive actions.
Adient’s cash balance gives it a runway to absorb seating-cycle volatility, but that runway only matters if it is not consumed by refinancing, restructuring or customer-volume shocks. Liquidity determines whether shareholders own a recoverable cyclical trough or a balance-sheet problem.
Adient’s scale creates shareholder value only if cost recovery and operating discipline flow through below gross profit into sustained GAAP net profitability. Without net profitability, the business may remain essential to OEMs but still fail to compound per-share value for owners.
All standing thesis claims
Original report summary
Adient is a cyclical automotive-seating turnaround whose upside depends on converting entrenched OEM program positions into durable cash profit despite weak supplier pricing power.
Bull case and bear case
Bull case and bear case for Adient
Where the evidence on Adient disagrees: Mixed on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 4 holding and 1 weakening.
Bull case: what the evidence supports
Adient’s embedded role in global OEM seating programs remains a real demand anchor, so losses of vehicle-platform awards should be cyclical and mix-driven rather than a structural share loss.
Adient can defend gross economics only if launch execution, purchasing discipline and customer cost recoveries offset OEM price pressure and input-cost inflation.
The turnaround remains financeable if Adient’s working-capital discipline, customer reimbursements and restructuring actions keep operating cash generation positive despite thin margins.
Adient’s cash balance gives it a runway to absorb seating-cycle volatility, but that runway only matters if it is not consumed by refinancing, restructuring or customer-volume shocks.
Bear case: what the evidence questions
Adient’s scale creates shareholder value only if cost recovery and operating discipline flow through below gross profit into sustained GAAP net profitability.
Thesis-Break Engine
What has broken in Adient’s thesis
Each break OptimistFi flagged on Adient, dated — with what has historically followed the same kind of break across the market, not a forecast for Adient.
- CEO / officer changecondition set before this filing
Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedDirector or principal officer change.
Adient filed an SEC 8-K on 2026-09-18: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
Adient filed an SEC 8-K on 2026-08-21: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
Adient filed an SEC 8-K on 2026-08-13: Regulation FD disclosure. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Lear, Forvia, Toyota Boshoku or other seating suppliers win major upcoming OEM platform awards that Adient previously held.
- OEMs impose price-downs or delay recovery of labor, freight, commodity or launch costs.
- OEM production cuts reduce plant utilization and delay receivable collection or tooling reimbursements.
- Debt maturities or refinancing occur at materially higher interest cost, reducing flexibility before operations recover.
- OEM pricing pressure permanently captures the benefit of Adient’s purchasing, footprint and launch improvements.
ADNT news
Loading headlines…
Financial statements
ADNT income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
ADNT: quick answers
- Have members of Congress traded ADNT?
- 7 trades in ADNT have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed ADNT trade
- Which well-known investors own ADNT?
- 1 of the 37 well-known funds tracked here reported ADNT shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
ADNT in well-known investors’ portfolios
1 of 37 funds reported ADNT shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.03% | $7.0M | +30.6% | Q2 2026 |
